Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

Cruz announces that investors with losses related to ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR ...

ICON plc, No. 25-cv-01807 ("PFRSD"). PFRSD is related to the class action an investor previously filed against ICON: Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.) ("Shing"), which is the first ...

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc ...

The first-filed case is Shing v. ICON plc, No. 25-cv-00763. A subsequent case, Police and Fire Retirement System of the City of Detroit v. ICON plc, No. 25-cv-1807, updated the Class Period.